Zoetis Inc. (ZTS): Capital Expenditures
$621.00M
Year ended 2025-12-31
+2.0%
3-year compound annual growth
+6.5%
5-year compound annual growth
+10.7%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $621.00M | -5.2% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | $655.00M | -10.5% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $732.00M | +24.9% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | $586.00M | +22.9% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $477.00M | +5.3% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $453.00M | -1.5% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $460.00M | +36.1% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $338.00M | +50.9% | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | $224.00M | +3.7% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $216.00M | -3.6% | 2019-02-14, From 2016-01-01 |
| 2015-12-31 | $224.00M | +24.4% | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $180.00M | -2.2% | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | $184.00M | +46.0% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $126.00M | -6.7% | 2015-02-27, From 2012-01-01 |
| 2011-12-31 | $135.00M | n/a | 2014-03-26, From 2011-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Zoetis Inc. (ZTS) | 2025-12-31 | $621.00M | -5.2% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $397.00M | +17.8% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $437.60M | +47.0% |
| Viatris Inc (VTRS) | 2025-12-31 | $378.80M | +16.2% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $898.40M | +18.9% |
| Organon & Co. (OGN) | 2025-12-31 | $162.00M | -7.4% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $185.84M | -62.3% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $501.00M | +0.6% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $276.00M | +87.8% |
Compare ZTS, BHC, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗